Glatiramer Acetate Treatment Directly Targets CD11b+Ly6G− Monocytes and Enhances the Suppression of Autoreactive T cells in Experimental Autoimmune Encephalomyelitis - Toker - 2011 - Scandinavian Journal of Immunology - Wiley Online Library
Links shared publicly online about this topic.
- 81total visits
Glatiramer Acetate Treatment Directly Targets CD11b+Ly6G− Monocytes and Enhances the Suppression of Autoreactive T cells in Experimental Autoimmune Encephalomyelitis - Toker - 2011 - Scandinavian Journal of Immunology - Wiley Online Library
Glatiramer Acetate Treatment Directly Targets CD11b+Ly6G− Monocytes and Enhances the Suppression of Autoreactive T cells in Experimental Autoimmune Encephalomyelitis - Toker - 2011 - Scandinavian Journal of Immunology - Wiley Online Library
View full resource at onlinelibrary.wiley.com
Tags: Allergy and Immunology, Multiple Sclerosis Medication, Copaxone
Most Recently Shared on August 11, 2011 at 3:55 am By:
Glatiramer Acetate Treatment Directly Targets CD11b+Ly6G− Monocytes and Enhances the Suppression of Autoreacti... http://bit.ly/qMOWJi
Neurology Article | Multiple Sclerosis
mdlinx.com — “Glatiramer acetate treatment directly targets CD11b+Ly6G- monocytes and enhances suppression of autoreactive T cells in EAE” View full resource at mdlinx.com
Most Recently Shared on May 21, 2011 at 6:08 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Glatiramer acetate treatment directly targets CD11b+Ly6G- monocytes and enhances suppression of autoreact... http://bit.ly/jpaOf7 #neuro
Advertisement
